Project Leader

Dr. Helma Rutjes
Head of R&D, Hycult Biotech, Uden, The Netherlands
Phone: +31 413 251335
Fax: +31 413 248353

Contact

Hycult Biotech is a company specialized in biomarker assay development in innate immunity, inflammation and tissue damage. Within the TranSVIR project biomarkers for multi-system inflammatory diseases will be evaluated. Special focus will be in the field of vascular damage, complement and pattern recognition molecules. At Hycult Biotech, studies will be performed to evaluate candidate biomarkers. For resulting potential biomarkers, assays will be developed and subsequently validated for clinical application by using well-defined patient samples.

Publications:

Dr Rutjes´ publications / papers

Institute Presentation

Hycult Biotech develops, produces and markets antibodies and antibody based products, especially immuno assays for innate immunity and directly related fields. Our mission and strategy is to advance the testing of innate immunity related diseases, for the benefit of individuals and their quality of life. Hycult Biotech specializes in unique mono- and polyclonal antibodies, recombinant proteins, peptides, ELISA kits in the field of Innate immunity, inflammation and cell- and tissue damage and more

Training

Hycult Biotech specializes in developing and manufacturing high quality antibodies, proteins/peptides and a wide variety of assays for biomedical research with a focus on innate immunity with special emphasis on endotoxins and other microbial toxins, complement, neutrophil proteins, coagulation, inflammation, oxidation and cell damage. Hycult Biotech has a strong focus on detection of cell and tissue damage, e.g. in liver, kidney, brain and intestine. HB has a team of academics and technical engineers highly experienced in development and production of recombinant proteins, antibodies and assays and the group includes specialists in cell biology, immunology and immunological assay development, which guarantees quality and services on the highest level.
Hycult Biotech is a company specialized in biomarker assay development in innate immunity, inflammation and tissue damage. Within the TranSVIR project biomarkers for multi-system inflammatory diseases will be evaluated. Special focus will be in the field of vascular damage, complement and pattern recognition molecules. Studies will be performed to evaluate candidate biomarkers and subsequently validated for clinical application by using well-defined patient samples.

Top